Live webinar on August 26, 2021 - 12 noon (BST) for fetal medicine experts, radiologists, obstetricians, sonographers, specialist midwives, neonatologists and trainees in these fields. During this interactive session you will hear about the latest research on managing complex MCDA twins from European and Asian experts.
Fetoscopic laser will be described, as will other established techniques such as radiofrequency ablation for selective FGR or twins discordant for anomalies. We will also spend a little time on ‘blue sky’ technologies that could enter clinical practice soon, such as non-invasive ablation using high intensity focused ultrasound. All the speakers are highly experienced in their fields and have an infectious enthusiasm to teach, debate and discuss.
This is the fourth in the “East meets West” Obstetrics and Gynaecology Ultrasound Webinar Series 2021 - supported by Samsung Medison - and brought to you by Profs Christoph Lees and Tom Bourne of Imperial College London, through Imperial Consultants.
Please find a full programme here
Places are limited, so register today to secure yours!
Perinatal Doppler and Vascular Focus Group (Chair), UOG Editorial Board
Christoph Lees is a Maternal-Fetal Medicine subspecialist, Consultant Obstetrician and Head of Fetal Medicine at Imperial College London where he is Clinical Reader. He is visiting Professor, KU Leuven, Belgium, was RCOG inaugural National Ultrasound Officer 2010-2013 and Vice Chairman, RCOG Subspecialty Committee 2011-2013. His research focuses on pre-eclampsia, cardiovascular adaptation, Doppler, intra-uterine growth restriction and non-invasive fetal surgery.
Specialties: Fetal anomaly screening T2; fetal biometry and wellbeing; aneuploidies; fetal anomalies; fetal growth restriction; maternal and fetal Doppler; preeclampsia; safety of ultrasound
Scientific Committee, China Task Force, UOG Editorial Board
Professor Liona Poon is an Academic Subspecialist in Maternal Fetal Medicine, devoted in improving maternal and fetal health. She has had a prolific research output throughout her clinical and research posts, including over 130 peer-reviewed publications in high impact international journals. In the last 10 years she has focused her research on establishing a programme for effective early prediction and prevention of preeclampsia, a major cause of maternal and perinatal morbidity and mortality. With her success in developing a first-trimester prediction model for preeclampsia using maternal risk factors, ultrasound, blood pressure and biochemical markers, and on Aspirin prophylaxis against preeclampsia, her goal in the next 10 years is to improve obstetric care worldwide, through clinical research and education.
Aspire trial: incidence of preterm preeclampsia in patients fulfulling ACOG and NICE criteria according to risk by the FMF algorithm. Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nikolaides KH.
Ultrasound Obstet Gynecol 2018 Jan 30. doi: 10.1002/uog.19019 [Epub ahead of print]
Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides K.H.
New England Journal Medicine 2017, 2017 Jun 28. doi: 10.1056/NEJMoa1704559. [Epub ahead of print]
Country: China, Hong Kong Special Administrative Region
Specialties: Fetal anomaly screening 1st trimester and 2nd trimester; fetal biometry and wellbeing; fetal anomalies screening; aneuploidy screening; fetal anomalies; fetal growth restriction; maternal and fetal Doppler; multiple pregnancy; preeclampsia; preterm delivery; fetal growth; detection of fetal and neonatal growth abnormalities; ultrasound on the labour ward
Languages: English; Chinese (Mandarin); Chinese (Cantonese)
Hye Sung Won is a leading clinician of the largest Fetal Treatment Center in Korea and there making clinical and academic progresses of fetal diagnosis and therapy possible to develop further both nationally and internationally.
She is exceptional in making diagnoses for cardiac abnormality including rare diseases, which is a very important part of perinatal counselling and management. She is the first clinician to do balloon aortic valvuloplasty for a fetus with severe aortic valve stenosis at 29 weeks of gestation in Korea. Moreover, she is specialized in prenatal diagnosis for various fetal disease and fetal therapy including shunt operation, fetal transfusion, radiofrequency ablation and fetoscopic laser surgery. She made over 500 cases of shunt operation for fetal pleural effusion, ascites, and lower urinary tract obstruction since 1999. She had done more than 200 cases of fetoscopic laser surgery for twin-to-twin transfusion syndrome, and the results showed high survival rate.
Dr Gowrishankar Paramasivam is currently the Director of Chennai Fetal Care in India. His most reent employment includes working as Senior Staff Specialist in fetal medicine at Queen Charlotte's and Chelsea Hospital (Imperial College Health Care NHS Truste) London. His academic employments include: Honorary Clinical Lecturer at Imperial College London; Adjunct Faculty at Department of Obstetrics and Gynecology, Manipal Academy of Higher Education (MAHE), Manipal, India; and Visiting Faculty at Department of Radiology and Imaging Sciences at Sri Ramachandra Medical College and Research Institute (SRIHER) in Chennai, India. Upon completion of postgraduate training in radiology, Dr Paramasivam moved to the UK in 2004 to pursue specialist training in fetal medicine and fetal interventions. He was trained by Prof. Kypros Nicolaides at the world-renowned Harris Birth Right Research Centre, Kings College Hospital and successfully obtained Diploma in Fetal Medicine. Dr Paramasivam also obtained RCOG/RCR Advanced Ultrasound Diploma in Obstetric Ultrasound and is also accredited by EBCOG (European Board and College of Obstetrics and Gynecology) and EAPM (European Association of Perinatal Medicine) for training in fetal medicine. Dr Paramasivam is trained by Prof. Mary Rutherford (Imperial College London) to interpret and report fetal MRI. He was awarded MD (Res) by Imperial College London for his study on 'Prelabour assessment of fetal cardiac function'. He has also worked and collaborated with international experts in the field of fetal medicine and has numerous publications in peer reviewed journals to his credit. He is currently involved in conducting joint fellowship training programme in Advanced Obstetric Ultrasound and Fetal Medicine with Manipal Academy of Higher Education, Manipal University, India.
Field: Obstetrics, Fetal Medicine
Specialties: Tertiary level fetal medicine scans across gestation, including specialised fetal echocardigraphy, management of high risk and complex pregnancy, routine fetal interventions (amniocentesis, chorion villous sampling, embryo and multifetal pregnancy reductions, insertions of fetal shunts - vesico amniotic, pleural shunts, etc.), management of high risk multiple pregnancy, including fetal interventions, expert in selective reduction of Monochorionic twins by Radio frequency ablation, fetal blood sampling (FBS) with intrauterine fetal transfusiions, fetoscopic laser ablation for twin-to-twin trasfusion syndrome (TTTs), fetal MRI and placental imaging in abnormally invasive placental disorders, advanced 3D imaging in fetal neurology and facial dysmorphology, expertise in management of IUGR, preeclampsia in singleton and multiple pregnancies.
Languages: Indian, English